OsI_014908 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
OsI_014908 antibody; OSIGBa0144C23.1Cysteine proteinase inhibitor 10 antibody; Oryzacystatin X antibody; OC-X antibody; Oryzacystatin-10 antibody
Target Names
OsI_014908
Uniprot No.

Target Background

Function
OsI_014908 Antibody is a specific inhibitor of cysteine proteinases. It is likely involved in the regulation of endogenous processes and in defense against pests and pathogens.
Protein Families
Cystatin family, Phytocystatin subfamily
Subcellular Location
Secreted.

Q&A

What is OsI_014908 Antibody and what is its target protein?

OsI_014908 Antibody is a rabbit polyclonal antibody that specifically recognizes Cysteine proteinase inhibitor 10 (also known as Oryzacystatin X or OC-X) from Oryza sativa subsp. indica (Rice). This target protein functions as a specific inhibitor of cysteine proteinases and is likely involved in the regulation of endogenous processes and defense mechanisms against pests and pathogens in rice plants . The antibody is produced through immunization with recombinant Oryza sativa subsp. indica OsI_014908 protein and is purified through antigen-affinity techniques to ensure specificity .

What are the key structural and functional characteristics of OsI_014908 Antibody?

The OsI_014908 Antibody is a polyclonal IgG antibody raised in rabbits. It has the following characteristics:

PropertySpecification
ClonalityPolyclonal
IsotypeIgG
HostRabbit
Species ReactivityOryza sativa subsp. indica (Rice)
Molecular Weight of Target15,448 Da
FormulationLiquid: 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH7.4
ApplicationsELISA, Western Blot
Storage-20°C or -80°C

The antibody recognizes the three-dimensional structure of the target protein, which is important for experimental applications requiring specific detection of the native protein .

What are optimal protocols for using OsI_014908 Antibody in Western Blot experiments?

For Western Blot applications using OsI_014908 Antibody, researchers should follow these methodological steps:

  • Sample Preparation: Extract proteins from rice tissues using an appropriate buffer containing protease inhibitors to prevent degradation.

  • Protein Separation: Run samples on SDS-PAGE gels (12-15% recommended due to the 15.4 kDa target size).

  • Transfer: Transfer proteins to PVDF or nitrocellulose membranes using standard protocols.

  • Blocking: Block membranes in 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

  • Primary Antibody Incubation: Dilute OsI_014908 Antibody (recommended starting dilution 1:1000) in blocking buffer and incubate overnight at 4°C.

  • Washing: Wash membranes 3-5 times with TBST.

  • Secondary Antibody: Incubate with appropriate anti-rabbit secondary antibody for 1 hour at room temperature.

  • Detection: Visualize using chemiluminescence, fluorescence, or colorimetric methods.

Similar methodological approaches can be applied to ELISA procedures, with appropriate modifications for the solid-phase format .

How should experimental controls be designed when using OsI_014908 Antibody?

Robust experimental design requires appropriate controls to validate antibody specificity and experimental outcomes:

Positive Controls:

  • Recombinant OsI_014908 protein

  • Rice tissue samples known to express high levels of Cysteine proteinase inhibitor 10

  • Overexpression systems expressing the target protein

Negative Controls:

  • Tissues from species not expected to cross-react with the antibody

  • Knockout/knockdown samples lacking the target protein

  • Pre-immune serum controls

  • Secondary antibody-only controls to detect non-specific binding

Validation Controls:

  • Peptide competition assays to confirm binding specificity

  • Multiple detection methods to corroborate findings

Incorporating these controls helps to distinguish true signals from experimental artifacts and provides confidence in the interpretation of results .

How can OsI_014908 Antibody be used to study plant defense mechanisms?

Cysteine proteinase inhibitors like Oryzacystatin X play crucial roles in plant defense against pathogens and pests. The OsI_014908 Antibody can be leveraged to investigate these mechanisms through several advanced approaches:

  • Immunolocalization Studies: Use the antibody for immunohistochemistry or immunofluorescence to visualize the spatial distribution of Cysteine proteinase inhibitor 10 in different plant tissues before and after pathogen challenge.

  • Protein-Protein Interaction Analysis: Employ the antibody in co-immunoprecipitation experiments to identify protein complexes involving OsI_014908 during pathogen response.

  • Expression Profiling: Use Western blot analysis with OsI_014908 Antibody to quantify protein expression levels across different stress conditions, developmental stages, or in response to biotic stressors.

  • Functional Inhibition Studies: Assess the impact of neutralizing the protein using the antibody in ex vivo systems to examine its role in defense cascades.

These approaches can help elucidate the molecular mechanisms by which Cysteine proteinase inhibitor 10 contributes to plant immunity, potentially informing crop protection strategies .

What computational approaches can enhance research involving OsI_014908 Antibody?

Computational methods are increasingly important for antibody research and can be applied to studies involving OsI_014908 Antibody:

  • Antibody Structure Modeling: Techniques similar to those used in RosettaAntibodyDesign can predict the structure of OsI_014908 Antibody, providing insights into its epitope recognition .

  • Antibody-Antigen Complex Prediction: Computational docking methods can predict how OsI_014908 Antibody interacts with its target protein, identifying key binding residues .

  • Epitope Mapping: In silico epitope prediction algorithms can help identify potential binding sites on the Cysteine proteinase inhibitor 10.

  • Molecular Dynamics Simulations: These can reveal allosteric effects during antibody-antigen recognition, which may influence experimental design and interpretation .

  • Cross-Reactivity Prediction: Computational approaches can predict potential cross-reactivity with other proteins, informing experimental controls and result interpretation.

These computational methods complement experimental approaches and can guide more efficient research designs with OsI_014908 Antibody .

What are common challenges when using OsI_014908 Antibody and how can they be addressed?

When working with OsI_014908 Antibody, researchers may encounter several technical challenges that require methodological refinements:

ChallengePossible CausesSolutions
Weak or no signalInsufficient antibody concentration, degraded antibody, low target expressionIncrease antibody concentration, verify antibody integrity, enrich target protein
High backgroundNon-specific binding, insufficient blocking, contaminated buffersOptimize blocking conditions, increase washing steps, filter buffers
Multiple bandsCross-reactivity, protein degradation, post-translational modificationsVerify specificity with controls, add protease inhibitors, analyze modifications
Inconsistent resultsVariable experimental conditions, antibody lot variationsStandardize protocols, use consistent lots when possible

For weak signals specifically, consider implementing signal amplification methods such as tyramide signal amplification or polymer-based detection systems to enhance sensitivity without increasing background .

How can binding kinetics and affinity of OsI_014908 Antibody be characterized?

Characterizing the binding properties of OsI_014908 Antibody provides valuable information for optimizing experimental conditions. Several methodological approaches can be used:

  • Surface Plasmon Resonance (SPR): This technique measures real-time binding kinetics without labels. Immobilize the target protein on a sensor chip and flow different concentrations of OsI_014908 Antibody to determine association (kon) and dissociation (koff) rate constants and calculate the equilibrium dissociation constant (KD).

  • Bio-Layer Interferometry (BLI): Similar to SPR but using optical interference patterns to measure binding events. This method requires less sample and can be performed in a high-throughput format.

  • Isothermal Titration Calorimetry (ITC): Measures the heat released or absorbed during binding to calculate thermodynamic parameters and binding stoichiometry.

  • Enzyme-Linked Immunosorbent Assay (ELISA): Multiple dilutions of antibody against a fixed amount of target can generate a binding curve from which relative affinity can be derived.

Understanding these parameters helps in determining optimal antibody concentrations for different applications and comparing the performance of different antibody lots .

How does post-translational modification analysis relate to OsI_014908 Antibody research?

Post-translational modifications (PTMs) can significantly affect protein function and antibody recognition. For OsI_014908 Antibody research, consider the following methodological approaches:

  • Identification of PTMs on Cysteine proteinase inhibitor 10: Use mass spectrometry to identify phosphorylation, glycosylation, or other modifications on the target protein.

  • Effect of PTMs on Antibody Recognition: Compare antibody binding to modified and unmodified forms of the protein using Western blot or ELISA.

  • Site-Directed Mutagenesis: Create mutants of the target protein where potential modification sites are altered to assess their impact on antibody binding.

  • 2D Western Blotting: Separate proteins by both isoelectric point and molecular weight to distinguish different post-translationally modified forms.

What approaches can be used to investigate the evolutionary conservation of epitopes recognized by OsI_014908 Antibody?

Understanding the evolutionary conservation of epitopes can provide insights into the fundamental importance of protein regions and help predict cross-reactivity with related species:

  • Sequence Alignment Analysis: Compare the amino acid sequences of Cysteine proteinase inhibitors across different plant species to identify conserved regions that might contain the epitope recognized by OsI_014908 Antibody.

  • Structural Homology Modeling: Build homology models of related inhibitors from different species to predict structural conservation of epitopes.

  • Cross-Reactivity Testing: Test the OsI_014908 Antibody against protein extracts from related plant species to experimentally determine cross-reactivity patterns.

  • Epitope Mapping: Use techniques such as peptide arrays or hydrogen/deuterium exchange mass spectrometry to precisely map the epitope recognized by the antibody.

  • Phylogenetic Analysis: Construct phylogenetic trees of cysteine proteinase inhibitors and correlate evolutionary distance with antibody binding affinity.

These approaches can help contextualize the specificity of OsI_014908 Antibody within the broader evolutionary landscape of plant protease inhibitors .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.